← Leaderboards
Wei Qiu
Loyola University Chicago
$4,908,273
Attributed
$4,908,273
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $674.6K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,908,273 · 6
By mechanism
R01$3,647,710 · 1
R21$804,563 · 2
R03$456,000 · 3
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- Joan Heller Brown$3,870,018
- Claudia Rose Keating$94,030
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularHepatocyteLiverPrimary Carcinoma Of The Liver CellsOverexpressionUnited StatesPlayMalignant NeoplasmsPhosphotransferasesMalignant Epithelial CellHepatocarcinogenesisCessation Of LifeInsightTherapeutic InterventionBeta CateninCellsFocal Adhesion Kinase 1MediatingKinase InhibitorSignal PathwayMouse ModelAnimalsSpecimenPhosphorylation
Grant awards (21)
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$375,106
R01 · FY2025 · CA · contact PI
Elucidating molecular mechanisms of cabozantinib resistance in liver cancer$77,000
R03 · FY2025 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$376,263
R01 · FY2024 · CA · contact PI
Defining the role of a novel hexokinase in alcoholic liver disease$221,375
R21 · FY2024 · AA · contact PI
Elucidating molecular mechanisms of cabozantinib resistance in liver cancer$77,000
R03 · FY2024 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$367,604
R01 · FY2023 · CA · contact PI
Defining the role of a novel hexokinase in alcoholic liver disease$182,875
R21 · FY2023 · AA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$367,604
R01 · FY2022 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$374,498
R01 · FY2021 · CA · contact PI
Defining the Role of ABL Kinases in Alcoholic Liver Disease$219,219
R21 · FY2021 · AA · contact PI
Defining the Role of ABL Kinases in Alcoholic Liver Disease$181,094
R21 · FY2020 · AA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$335,130
R01 · FY2019 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$56,802
R01 · FY2019 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$345,493
R01 · FY2018 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$346,980
R01 · FY2017 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$351,229
R01 · FY2016 · CA · contact PI
The role of Sirt2 in haptocarcinogenesis$75,500
R03 · FY2016 · CA · contact PI
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis$351,001
R01 · FY2015 · CA · contact PI
The role of FAK in hepatocarcinogenesis$75,500
R03 · FY2015 · CA · contact PI
The role of Sirt2 in haptocarcinogenesis$75,500
R03 · FY2015 · CA · contact PI
The role of FAK in hepatocarcinogenesis$75,500
R03 · FY2014 · CA · contact PI